Department of Pathology, HUSLAB and University of Helsinki, Finland.
Acta Oncol. 2012 Jul;51(6):706-12. doi: 10.3109/0284186X.2011.643821. Epub 2012 Jan 10.
A prospective diagnostics and treatment protocol for extremity and trunk wall soft tissue sarcoma (STS) was introduced by the Scandinavian Sarcoma Group in 1986 and it was also widely adopted in Finland. We have updated the protocol and made it more detailed at the Helsinki University Central Hospital. We retrospectively compared diagnostics and treatment of STS in a nationwide population-based material to this protocol with special emphasis on local control.
Data for 219 patients with an STS of extremity or trunk wall diagnosed during 1998-2001 was retrieved from the nationwide Finnish Cancer Registry. Histologic review was performed. Treatment centres were divided into high-, intermediate- and low-volume centres based on the number of patients with final surgery during the study period.
Significantly more patients were operated with a preoperative histological or cytological diagnosis at high-volume centres. No preoperative diagnosis was a strong predictor for the patient to undergo more than one operation (p < 0.0001). Wide surgical margin was achieved more often at high-volume centres, but in all centre categories a considerable percentage of patients with inadequate surgical margin did not receive adjuvant radiation therapy. Local control at five years was 82% at high-volume centres, 61% at intermediate-volume centres treating highest percentage of deep tumours and 69% at low-volume centres (p = 0.046). Local control improved as the number of patients operated (surgical volume of the centre) increased.
The present quality-control study is the first nationwide population-based study to assess diagnostics and treatment of STS. When referred to a specialised sarcoma centre even patients with inadequate surgery can achieve good local control. STS is a rare cancer and its treatment should be centralised in Finland, which has 5.4 million inhabitants and approximately 100 new STSs of extremities and trunk wall annually.
1986 年,斯堪的纳维亚肉瘤研究组提出了一项针对肢体和躯干壁软组织肉瘤(STS)的前瞻性诊断和治疗方案,该方案在芬兰也得到了广泛应用。我们对该方案进行了更新,并在赫尔辛基大学中心医院使其更加详细。我们回顾性地比较了全国人群 STS 的诊断和治疗与该方案,特别强调了局部控制。
从全国芬兰癌症登记处检索了 1998-2001 年间诊断为肢体或躯干壁 STS 的 219 例患者的数据。进行了组织学审查。根据研究期间最终接受手术的患者数量,将治疗中心分为高、中、低容量中心。
高容量中心进行术前组织学或细胞学诊断的患者明显增多。没有术前诊断是患者接受多次手术的强烈预测因素(p < 0.0001)。高容量中心更常获得广泛的手术切缘,但在所有中心类别中,相当比例的手术切缘不足的患者未接受辅助放疗。高容量中心的五年局部控制率为 82%,中容量中心(治疗深部肿瘤比例最高)为 61%,低容量中心为 69%(p = 0.046)。随着手术患者数量(中心手术量)的增加,局部控制情况得到改善。
本质量控制研究是首次评估 STS 诊断和治疗的全国性基于人群的研究。即使患者手术不充分,转诊至专门的肉瘤中心也能获得良好的局部控制。STS 是一种罕见的癌症,芬兰拥有 540 万居民,每年约有 100 例新的肢体和躯干壁 STS,其治疗应集中进行。